Table 1

Antibody tests against deamidated gliadin (dpgli) vs. native gliadin (ngli) in 149 CD patients and 119 controls
IgA anti-ngli IgA anti-dpgli IgG anti-ngli IgG anti-dpgli
Sensitivity 61% 78% 79% 85%
Specificity 97% 97% 68% 92%
Positive predictive value 97% 97% 76% 93%
Negative predictive value 67% 78% 72% 83%

McNemar’s test for significant changes p < 0.00001.

61 correct changes; 154 remain correct; 7 wrong changes; 46 remain wrong.

Bürgin-Wolff et al.

Bürgin-Wolff et al. BMC Gastroenterology 2013 13:19   doi:10.1186/1471-230X-13-19

Open Data